Director, HTA, Value & Evidence (HV&E), Internal Medicine Early Pipeline
Location: United States – New York, New York City
Overview
Responsible for driving optimal patient access for Pfizer’s portfolio of obesity and non‑obesity products in the early pipeline by leading evidence generation and strategic value development.
Key Responsibilities
Provide strategic input into clinical trial designs and analyses to support successful negotiations and reimbursement.
Lead development and execution of the evidence generation strategy for Internal Medicine assets.
Coordinate input from local country and regional teams to integrate into the global evidence strategy.
Design and execute global HEOR studies (network meta‑analyses, non‑interventional studies, economic models) from concept through publication.
Develop patient‑reported outcomes strategy and incorporate humanistic and economic endpoints into all product development phases.
Ensure customer‑facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
Build strategic partnerships and research collaborations with external experts, payers, and academic/community settings.
Basic Qualifications
Graduate degree required (MSc, MPH, PhD, or equivalent). 7+ years of experience with MSc/MPH/MBA, 5+ years with PharmD/PhD/DrPH in HEOR or related fields.
Expertise in HEOR strategy, health economic modeling, patient‑reported outcomes, statistics, and real‑world evidence studies.
Capacity to independently manage complex non‑interventional study projects.
Knowledge of the drug development process.
Excellent interpersonal, oral, and written communication skills.
Demonstrated ability to assess anticipated value, prioritize projects, and operate within a matrix organization.
Strong project management skills (contracting, budgeting, vendor management, stakeholder engagement).
Leadership experience in cross‑functional teams and mentoring of junior members.
Organized, detail‑oriented, and adaptable to changing priorities and tight timelines.
Preferred Requirements
Knowledge and experience in obesity/internal medicine space.
Experience with HTA organizations such as NICE, CADTH, PBAC, ICER, and other HTA bodies.
Early‑stage development, clinical trial, and patient‑reported outcomes experience.
Design and implementation of large‑scale observational studies.
Early economic modeling to inform clinical development and pricing.
Support for global obesity/internal medicine launch.
Proficiency with AI tools (e.g., ChatGPT, Microsoft Copilot) and understanding of responsible AI practices.
Other Job Details
Last Date to Apply: May 15th, 2026
Ability to travel domestically and internationally.
Ability to work in all U.S. time zones.
Location: U.S. Pfizer sites or European Pfizer sites.
Not eligible for relocation package; relocation assistance may be available based on business needs.
Hybrid position, requires onsite work 2–3 days per week.
Compensation & Benefits
Annual base salary range: $176,600 – $294,300.
Eligible for participation in Pfizer’s Global Performance Plan (bonus target 20.0% of base salary).
Eligibility to participate in share‑based long‑term incentive program.
Comprehensive benefits: 401(k) plan with matching contributions, retirement savings contribution, paid vacation, holidays, personal days, caregiver/parental and medical leave; health, prescription drug, dental, and vision coverage.
EEO & Employment Eligibility
Pfizer is an equal‑opportunity employer. This position requires permanent work authorization in the United States.
Sunshine Act Disclosure
Pfizer reports payments to healthcare providers as required by transparency laws. If you are a licensed physician and incur recruiting expenses reimbursed by Pfizer, those expenses may be reported.
#J-18808-Ljbffr